Hannover Medical School, Germany
Patients with Marfan syndrome and Loeys-Dietz syndrome show overlapping genetic profiles
Published in Pharma Investments, Ventures and Law Weekly, October 1st, 2006
According to recent research from Germany, "MFS is an autosomal dominant connective tissue disorder characterized by manifestations in the cardiovascular, skeletal, ocular, and other organ systems. MFS type-1 (MFS1) is caused by mutations in the gene encoding fibrillin (FBN1)."
"Recently, the transforming growth factor-beta receptor-2 gene, TGFBR2, has been shown to be associated with a second type of this disorder with typically mild or absent ocular involvement (MFS type 2; MFS2). Several point mutations were found in the highly conserved serine/threonine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- AGA Medical
AGA Medical files suit in Germany alleging patent infringement - Ablynx
Ablynx completes EUR 40 million series C financing - Advanced Biotherapy
Advanced Biotherapy enters into share purchase and debt restructure agreement - Affymetrix
Affymetrix files restated financial statements - Amylin Pharmaceuticals
Amylin converts all outstanding 2.25% convertible senior notes due 2008 - Bradley Pharmaceuticals
Bradley Pharmaceuticals announces initiatives to enhance shareholder value - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
